{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:13:51Z","timestamp":1789906431109,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.clnesp.2021.08.005","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T10:58:48Z","timestamp":1630753128000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight\/obese women with polycystic ovary syndrome: A randomized controlled trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Abbas Ali","family":"Sangouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Sasanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ghadiri-Anari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-2494","authenticated-orcid":false,"given":"Mahdieh","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2021.08.005_bib1","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40618-017-0762-3","article-title":"Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index","volume":"41","author":"Condorelli","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.clnesp.2021.08.005_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","article-title":"Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review","volume":"2","author":"Harris","year":"2016","journal-title":"Fertil Res Pract"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib6","first-page":"364","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib7","first-page":"1","article-title":"Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines","volume":"56","author":"Carmina","year":"2004","journal-title":"Minerva Ginecol"},{"issue":"6","key":"10.1016\/j.clnesp.2021.08.005_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib10","first-page":"262","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"16","author":"Barber","year":"2016","journal-title":"Clin Med J R Coll Physicians London"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.clnesp.2021.08.005_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/cen.12287","article-title":"Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study","volume":"81","author":"Hosseinpanah","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-017-0206-2","article-title":"Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults","volume":"14","author":"Dai","year":"2017","journal-title":"Nutr Metab"},{"issue":"8","key":"10.1016\/j.clnesp.2021.08.005_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","article-title":"Cardiovascular disease risk in women with PCOS","volume":"78","author":"Dokras","year":"2013","journal-title":"Steroids"},{"issue":"5","key":"10.1016\/j.clnesp.2021.08.005_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","article-title":"Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses","volume":"50","author":"Fern\u00e1ndez-Mac\u00edas","year":"2019","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5152\/eurasianjmed.2019.18350","article-title":"The clinical importance of the plasma atherogenic index, other lipid indexes, and urinary sodium and potassium excretion in patients with stroke","volume":"51","author":"Koca","year":"2019","journal-title":"Eurasian J Med"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.005_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American association of clinical endocrinologists, American college of endocrinology, and androgen excess and pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - Part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib19","first-page":"392","article-title":"Effects of L-carnitine on polycystic ovary syndrome","volume":"23","author":"Salehpour","year":"2019","journal-title":"J\u00a0Bras Reprod Assist"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an endocrine society","volume":"103","author":"Martin","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/humrep\/deg105","article-title":"Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial","volume":"18","author":"George","year":"2003","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/humrep\/del407","article-title":"Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis","volume":"22","author":"Nader","year":"2007","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0015-0282(99)00584-1","article-title":"Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression","volume":"73","author":"Branigan","year":"2000","journal-title":"Fertil Steril"},{"issue":"5\u20136","key":"10.1016\/j.clnesp.2021.08.005_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.mam.2004.06.006","article-title":"Carnitine: a nutritional, biosynthetic, and functional perspective","volume":"25","author":"Steiber","year":"2004","journal-title":"Mol Aspect Med"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2015.09.004","article-title":"Disorders of carnitine biosynthesis and transport","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metabol"},{"issue":"Pt 2","key":"10.1016\/j.clnesp.2021.08.005_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.2006.125799","article-title":"New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle","volume":"581","author":"Stephens","year":"2007","journal-title":"J\u00a0Physiol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12958-018-0323-4","article-title":"Role of L-carnitine in female infertility","volume":"16","author":"Agarwal","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.clnesp.2021.08.005_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.anireprosci.2012.08.013","article-title":"Promoting lipid utilization with l-carnitine to improve oocyte quality","volume":"134","author":"Dunning","year":"2012","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.clnesp.2021.08.005_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2019.09.010","article-title":"Sex hormone-binding globulin and polycystic ovary syndrome","volume":"499","author":"Zhu","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/j.clnesp.2021.08.005_bib30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0033-1361176","article-title":"CoQ10 and L-Carnitine attenuate the effect of high LDL and oxidized LDL on spermatogenesis in male rats","volume":"64","author":"Ghanbarzadeh","year":"2013","journal-title":"Drug Res"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MED.0b013e328353732f","article-title":"Evolving utility of sex hormone-binding globulin measurements in clinical medicine","volume":"19","author":"Hammond","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.005_bib32","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/den109","article-title":"Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome","volume":"23","author":"Fenkci","year":"2008","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.clnesp.2021.08.005_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.nutres.2015.06.003","article-title":"L-Carnitine supplementation improved clinical status without changing oxidative stress and lipid profile in women with knee osteoarthritis","volume":"35","author":"Malek Mahdavi","year":"2015","journal-title":"Nutr Res"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00125-007-0605-4","article-title":"Carnitine revisited: potential use as adjunctive treatment in diabetes","volume":"50","author":"Power","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2021.08.005_bib35","first-page":"359","article-title":"Effect of L-Carnitine supplementation on serum adipokines (Leptin and Visfatin) levels in obese type II diabetes mellitus women with Hypocaloric diet","volume":"10","author":"Barzegar","year":"2013","journal-title":"Life Sci J"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-011-0284-2","article-title":"Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in\u00a0vivo and in\u00a0vitro studies with carnitine supplementation and carnitine deficiency","volume":"51","author":"Ringseis","year":"2012","journal-title":"Eur J Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.005_bib37","article-title":"Improvement of insulin resistance via increase of GLUT4 and PPAR\u03b3 in metabolic syndrome-induced rats treated with omega-3 fatty acid or l-carnitine","volume":"32","author":"Zayed","year":"2018","journal-title":"J\u00a0Biochem Mol Toxicol"},{"issue":"6","key":"10.1016\/j.clnesp.2021.08.005_bib38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/cen.13003","article-title":"Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"84","author":"Samimi","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.clnesp.2021.08.005_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2288-4-26","article-title":"Random allocation software for parallel group randomized trials","volume":"4","author":"Saghaei","year":"2004","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clnesp.2021.08.005_bib40","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2014009","article-title":"Dietary assessment methods in epidemiologic studies","volume":"36","author":"Shim","year":"2014","journal-title":"Epidemiol Health"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib41","first-page":"204","article-title":"A\u00a0comprehensive review on dietary assessment methods in epidemiological research","volume":"3","author":"Rupasinghe","year":"2020","journal-title":"J\u00a0Public Heal Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/jfca.1999.0867","article-title":"USDA's national food and nutrient analysis program: Food sampling","volume":"13","author":"Pehrsson","year":"2000","journal-title":"J\u00a0Food Compos Anal"},{"issue":"9 Suppl","key":"10.1016\/j.clnesp.2021.08.005_bib43","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","article-title":"Compendium of physical activities: an update of activity codes and MET intensities","volume":"32","author":"Ainsworth","year":"2000","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"10.1016\/j.clnesp.2021.08.005_bib44","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ije\/dyu058","article-title":"Indices of relative weight and obesity","volume":"43","author":"Keys","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.clnesp.2021.08.005_bib45","first-page":"979","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"43","author":"Kahn","year":"2002","journal-title":"J\u00a0Lipid Res"},{"issue":"7","key":"10.1016\/j.clnesp.2021.08.005_bib46","first-page":"BC05","article-title":"A\u00a0study on atherogenic indices of pregnancy induced hypertension patients as compared to normal pregnant women","volume":"9","author":"Singh","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib47","first-page":"78","article-title":"Atherogenic indices in stroke patients: a retrospective study","volume":"16","author":"Sujatha","year":"2017","journal-title":"Iran J Neurol"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3945\/ajcn.2008.26251","article-title":"L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes","volume":"89","author":"Malaguarnera","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2021.08.005_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12944-016-0277-5","article-title":"Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease","volume":"15","author":"Lee","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"10","key":"10.1016\/j.clnesp.2021.08.005_bib50","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/obr.12436","article-title":"The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Pooyandjoo","year":"2016","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.clnesp.2021.08.005_bib51","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2015.07.009","article-title":"L-Carnitine enhances exercise endurance capacity by promoting muscle oxidative metabolism in mice","volume":"464","author":"Kim","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.clnesp.2021.08.005_bib52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/jmf.2006.9.468","article-title":"L-carnitine stimulates lipolysis via induction of the lipolytic gene expression and suppression of the adipogenic gene expression in 3T3-L1 adipocytes","volume":"9","author":"Lee","year":"2006","journal-title":"J\u00a0Med Food"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","article-title":"Nutraceuticals and dyslipidaemia: beyond the common therapeutics","volume":"6","author":"Scicchitano","year":"2014","journal-title":"J\u00a0Funct Foods"},{"issue":"1","key":"10.1016\/j.clnesp.2021.08.005_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000355751","article-title":"Influence of L-Carnitine supplementation on serum lipid profile in Hemodialysis Patients: a systematic review and meta-analysis","volume":"38","author":"Huang","year":"2014","journal-title":"Kidney Blood Pres Res"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.005_bib55","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.numecd.2019.07.012","article-title":"Efficacy of L-carnitine supplementation for management of blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials","volume":"29","author":"Askarpour","year":"2019","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"Suppl4","key":"10.1016\/j.clnesp.2021.08.005_bib56","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0272-6386(03)00112-4","article-title":"The role of carnitine in normal and altered fatty acid metabolism","volume":"41","author":"Hoppel","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.clnesp.2021.08.005_bib57","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"11","key":"10.1016\/j.clnesp.2021.08.005_bib58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10815-012-9855-2","article-title":"Carnitine content in the follicular fluid and expression of the enzymes involved in beta oxidation in oocytes and cumulus cells","volume":"29","author":"Montjean","year":"2012","journal-title":"J\u00a0Assist Reprod Genet"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772100293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772100293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:01:43Z","timestamp":1762498903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772100293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":58,"alternative-id":["S240545772100293X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.005","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight\/obese women with polycystic ovary syndrome: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}